Publications by authors named "Jacqueline Frippiat"
Article Synopsis
- A study was conducted to evaluate how effective complex decongestive therapy (CDT) is for patients with breast cancer-related lymphedema (BCRL), focusing on its impact on limb volume and functionality after treatment.
- The study included 142 patients undergoing 499 treatments, revealing a 50% reduction in limb volume and a 30% improvement in functioning, particularly when treatment was given for the first time and the patient's starting volume was low.
- The results suggest that early and intensive CDT is crucial for managing BCRL, as it enhances volume control and functionality, emphasizing the importance of timely intervention.
SurLym trial: study protocol for a multicentre pragmatic randomised controlled trial on the added value of reconstructive lymphatic surgery to decongestive lymphatic therapy for the treatment of lymphoedema.
Nele Devoogdt Tessa De Vrieze An-Kathleen Heroes Beate Bechter-Hugl Steffen Fieuws Jacqueline Frippiat
BMJ Open
May 2024
Introduction: Lymphoedema is a chronic condition caused by lymphatic insufficiency. It leads to swelling of the limb/midline region and an increased risk of infection. Lymphoedema is often associated with mental and physical problems limiting quality of life.
View Article and Find Full Text PDFPurpose: Upper limb lymphedema is a vexing morbidity that can occur after the treatment for breast cancer. The Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL) is a valid and reliable tool assessing problems in functioning in patients with breast cancer-related lymphedema. Until now, a French-language version was lacking.
View Article and Find Full Text PDF